Log in
NYSEARCA:GUSYX

Grandeur Peak US Stalwarts - Institutional Stock Forecast, Price & News

$17.79
+0.02 (+0.11 %)
(As of 10/20/2020 12:00 AM ET)
Add
Today's Range
$17.79
Now: $17.79
$17.79
50-Day Range
$15.85
MA: $16.74
$18.03
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Basic Details

Issuer
Fund NameGrandeur Peak US Stalwarts - Institutional
Tax Classification
SymbolNYSEARCA:GUSYX
Inception Date1/1/2100
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset Class
Benchmark
Category
Focus
Development Level
Region

Fund Statistics

Assets Under Management$1.19 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.00%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market Maker
$17.79
+0.02 (+0.11 %)
(As of 10/20/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GUSYX News and Ratings via Email

Sign-up to receive the latest news and ratings for GUSYX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Grandeur Peak US Stalwarts - Institutional (NYSEARCA:GUSYX) Frequently Asked Questions

What is Grandeur Peak US Stalwarts - Institutional's stock symbol?

Grandeur Peak US Stalwarts - Institutional trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "GUSYX."

How do I buy shares of Grandeur Peak US Stalwarts - Institutional?

Shares of GUSYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Grandeur Peak US Stalwarts - Institutional's stock price today?

One share of GUSYX stock can currently be purchased for approximately $17.79.

This page was last updated on 10/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.